<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2014.42016</article-id><article-id pub-id-type="publisher-id">AID-46632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>MEDICINE &amp; HEALTHCARE</subject></subj-group></article-categories><title-group><article-title>Prevalence, Incidence and Risk Factors for Acquisition of Herpes Simplex Virus Type 2 among Fishermen on the Shores of Lake Victoria in Kisumu County, Kenya</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raphael</surname><given-names>O. Ondondo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zipporah</surname><given-names>W. Ng’ang’a</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Solomon</surname><given-names>Mpoke</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Michael</surname><given-names>K. Kiptoo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elizabeth</surname><given-names>A. Bukusi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Kenya Medical Research Institute (KEMRI), Nairobi, Kenya</addr-line></aff><aff id="aff2"><addr-line>Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>raphondondo@gmail.com(ROO)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>06</month><year>2014</year></pub-date><volume>04</volume><issue>02</issue><fpage>101</fpage><lpage>110</lpage><history><date date-type="received"><day>21</day>	<month>April</month>	<year>2014</year></date><date date-type="rev-recd"><day>21</day>	<month>May</month>	<year>2014</year>	</date><date date-type="accepted"><day>30</day>	<month>May</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
	Background: Herpes simplex virus Type 2 (HSV-2) has
been associated with HIV infection. More recently, HSV-2 incidence has been
linked to HIV acquisition. A few studies have suggested that the fishing
communities have a high HSV-2 prevalence but there is limited knowledge on
HSV-2 incidence and associated risk factors among fishermen. Methods: Three
hundred fishermen were consented, and evaluated for baseline HSV-2 serology
status and again after 12 months among those negative at baseline. Sexual
behavior and socio-demographic data were collected at enrolment and exit visits
using a structured questionnaire. Baseline HIV serology and Human
papillomavirus (HPV) DNA genotyping were also performed. Multivariate logistic
regression was used to determine independent factors associated with HSV-2
acquisition. Results: Baseline HSV-2 prevalence was 56.3% (95% CI: 50.7 -
62.0). Factors associated with HSV-2 prevalence were, older age (aOR = 1.96;
95% CI: 1.16 - 2.85), history of STI (aOR 2.12; 95% CI: 1.19 - 3.91), infection
with HIV (aOR 2.22; 95% CI: 1.17 - 4.22), ever married (aOR = 3.80; 95% CI:
1.42 - 11.90), most recent sexual act with sex worker/casual partner (OR= 3.56;
95% CI: 1.49 - 8.62) and inconsistent condom use with new sexual partner (aOR =
6.34; 95% CI: 2.24 - 13.04). The HSV-2 incidence was 23.6 (95% CI = 15.4 -
31.8)/100 pyr. Infection with persistent high-risk (HR) HPV (aIRR = 3.35; 95%
CI: 1.21 - 11.37), multiple (≥2)
partners in 12 months prior to study participation (aIRR = 4.77; 95% CI: 1.12 -
11.38), inconsistent condom use with new partner (aIRR =2.53; 95% CI: 1.12 -
7.38) and most recent sexual act with sex worker/casual partner (OR = 3.03; 95%
CI: 1.17 - 8.58) were independent risk factors for HSV-2 acquisition.
Conclusion: The incidence of HSV-2 is very high among fishermen. It is
associated with persistent HR HPV infection and high-risk sexual behavior.
Intervention strategies targeting these men with high risk sexual behavior are
urgently needed to stop new HSV-2 acquisition and subsequently prevent HIV
infection. 
</p></abstract><kwd-group><kwd>Fishermen</kwd><kwd> Risk Factors</kwd><kwd> HSV-2 Incidence</kwd><kwd> HSV-2 Prevalence</kwd><kwd> HPV</kwd><kwd> HIV</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Genital ulcer disease (GUD) is clearly associated with increased risk of HIV acquisition and transmission. The genital ulcerations facilitate increased shedding and easier entry of HIV into the host [<xref ref-type="bibr" rid="scirp.46632-ref1">1</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref3">3</xref>] . Therefore, it is biologically plausible that presence of herpetic lesions would increase the risk of HIV acquisition. Herpes simplex virus type-2 (HSV-2) is one of the most prevalent sexually transmitted infections worldwide and the important leading cause of GUD ahead of syphilis and chancroid [<xref ref-type="bibr" rid="scirp.46632-ref4">4</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref6">6</xref>] . Epidemiological studies have established a strong association between prevalent HSV-2 and incident HIV infection [<xref ref-type="bibr" rid="scirp.46632-ref7">7</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref14">14</xref>] . Recent studies further suggest that incident HSV-2 infection increases the risk for new HIV infection [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref16">16</xref>] . In summary, underlying HSV-2 infection substantially elevates the risk of incident HIV infection. Therefore, prevalent and incident HSV-2 infection is indicated as a significant risk factor or co-factor for new HIV acquisition.</p><p>Fishing communities are composed of a sub-population of men and women with high-risk sexual behavior [<xref ref-type="bibr" rid="scirp.46632-ref17">17</xref>] biologically demonstrated by high HIV and/or HSV-2 prevalence [<xref ref-type="bibr" rid="scirp.46632-ref18">18</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref22">22</xref>] . Moreover, HIV incident rates are reportedly much higher among fishing communities than in the general population [<xref ref-type="bibr" rid="scirp.46632-ref23">23</xref>] . Although previous studies have evaluated risk factors for incident HSV-2 infection among individuals with high-risk sexual behavior [<xref ref-type="bibr" rid="scirp.46632-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref24">24</xref>] , there is limited knowledge on HSV-2 incidence among fishing communities in Sub-Saharan Africa; the epicenter of the HIV epidemic. Knowledge of HSV-2 acquisition risk factors is needed in the design of targeted interventions to limit incident HSV-2 infection and potentially lowering rates of new HIV infection. In this study, we report the results of the first study to evaluate the incidence and risk factors for HSV-2 infection among fishermen on the shores of Lake Victoria, Kisumu, Kenya.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Study Design and Clinical Procedures</title><p>Between September and December 2011, fishermen along beaches on the Kenyan side of Lake Victoria in Kisumu County were consented into a prospective study evaluating risk factors for HSV-2 acquisition. Sexually active fishermen aged 18 - 47 years were eligible for the one year study whose follow-up was concluded in December 2012. Blood samples for HSV-2 serologic testing were collected at baseline and after 12 months of follow-up for incidence rate among men negative for HSV-2 at baseline. Genital examination for clinical STIs and collection of genital swabs (from the glans, head, shaft, scrotum and perineum) for human papillomavirus (HPV) testing was performed at an interval of 3 months for the entire study period. Baseline HIV and HPV genotype status were determined as part of potential background risk factors for HSV-2 infection. Data on socio-demographic characteristics and sexual risk behavior was collected through interviewer administered structured questionnaire at enrollment and at study exit (month 12). Kenya Medical Research Institutes Scientific and Ethical Review Committees provided ethical clearance for the study protocol (SSC No.2014).</p></sec><sec id="s2_2"><title>2.2. Laboratory Detection of HSV-2, HIV and HPV</title><p>HSV-2 infection was determined by HSV-2 enzyme-linked immunosorbent assay (ELISA) (Kalon Biological Ltd, Guilford, UK), as per the manufacturer’s instructions. Men negative for HSV-2 serology were evaluated for HSV-2 incidence at the end of 12 month study follow-up. HIV status was determined using two rapid screening tests in parallel and confirmed by two separate ELISA tests. Determine (ABBOTT Laboratories, Diagnostic division, Chicago IL, USA) and UniGold HIV 1/2 rapid kit (Trinity Biotech, Ireland USA) with all concordant HIV positive or HIV discordant results confirmed by enzyme immunoassays: Vironostika ELISA (BioMerieuxVironostika HIV Uni-Form II plus O Antigen/Antibody ELISA, Marcy l’Etoile, France) and Murex HIV 1/2 Combo (Murex Biotech Limited, Dartford, UK). HPV infection was determined by polymerase chain reaction (PCR) using PGMY11/09 primer set and detection by genotype-specific probes multiplex Luminex assay for 33 important genital HPV genotypes; high-risk (HR) HPV genotypes: 16,18,26,31,33,35,39,45,51,52,53,55,56,58, 59,66,68,73,82,83 and low-risk (LR) HPV genotypes: 6,11,40,42,54,61,62,67,70,72,81,84, CP6108. Persistent HPV infection defined as detection of the same genotype at two consecutive visits ≥6 months apart was determined at subsequent visits.</p></sec><sec id="s2_3"><title>2.3. Statistical Analysis</title><p>HSV-2 incidence rate and person-time calculations were performed with the assumption that HSV-2 infection occurred at any time between baseline HSV-2 negative serologic test and study exit (after 12 months) positive serological test. HSV-2 incidence was estimated per 100 person-years (pyr). For HSV-2 prevalence analyses, associations with fixed covariates such as age, marital status, and HPV/HIV status at enrollment, as well as sexual risk behavior (number of sexual partners, sexual relationships and condom use) reported at baseline and exit of the study during were determined by chi square, logistic regression and Fisher’s exact for smaller numbers (≤6). Risk factors with a P value less than 0.10 in bivariate logistic regression were entered into a multivariate multiple logistic regression model to estimate adjusted measures of association for HSV-2 prevalence (aOR) and incidence rate ratio (aIRR) at 95% confidence interval (95% CI) for HSV-2 acquisition. SPSS version 19 (SPSS, Chicago, IL) and Stataversion 12 (StataCorp LP 4905 Lakeway Drive College Station, Texas 77845 USA) were used.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Of the 300 fishermen that were enrolled between September 2011 and December 2012, 254 (85%) returned for the scheduled annual exit visit. Enrolled men had median (IQR) age of 26.5 (21 - 32), median (IQR) 8 (5 - 15) number of sexual partners lifetime, and 2 (1 - 3) one year prior to study participation. The majority (91%) earned ≤ KShs 10,000 (110 USD)/month and only 24% were circumcised (<xref ref-type="table" rid="table1">Table 1</xref>). All men with baseline and study exit HSV-2 serology data were included in this study. At baseline, 169 men were detected with HSV-2. Of the 131 men who were negative for HSV-2 at baseline, 106 (81%) retuned for their exit visit and were significantly younger mean (SD) age 25.8 (5.84) years compared to men infected with HSV-2 at baseline (mean age 29.3, SD &#177; 6.37).</p><p>Baseline HSV-2 prevalence was 56.3% (95% CI: 50.7 - 62.0). Persons with prevalent HSV-2 infection were more likely to be older (&gt;28 years old) (70% vs. 49%), married (62% vs. 34%), HIV-1 positive (76% vs. 50%), ever had an STI (71% vs. 51.1%) and co-infected with HPV (62% vs. 50%) as shown in <xref ref-type="table" rid="table1">Table 1</xref>. Bivariate analysis revealed that older age (OR, 2.41; 95% CI, 1.42 - 4.11), ever married (OR, 2.13; 95% CI, 1.02 - 4.93), HIV infection (OR, 3.06; 95% CI, 1.67 - 5.61), HPV infection (OR, 1.64; 95% CI, 1.03 - 2.60), history of STI (OR, 2.41; 95% CI, 1.38 - 4.22) and lack of condom use (OR, 5.31; 95% CI, 2.29 - 12.33) were associated with HSV-2 prevalence. Additionally, among married fishermen, most recent sexual act with partner other than the wife was associated with increased odds of HSV-2 infection; girlfriend (OR, 2.58; 95% CI, 1.17 - 5.71) or casual partner/sex worker (OR, 3.56; 95% CI, 1.49 - 8.62). On the multivariate model, lack of condom use (aOR, 6.34; 95% CI, 2.24 - 13.04), HIV-1 positive (aOR, 2.22; 95% CI, 1.17 - 4.22), and history of STI (aOR, 2.12; 95% CI, 1.19 - 3.91) were independently associated with HSV-2 prevalence (<xref ref-type="table" rid="table2">Table 2</xref>). Among men with baseline HSV-2 infection, 93 (55%) were positive for HPV DNA, of which 70 (75%) were at least infected with a HR HPV genotype. Similar HPV proportions were observed among HSV-2 negative men; 75% (42/56) of HPV positive men had at least one HR HPV genotype. Baseline HPV infection was not associated with HSV-2 prevalence (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Among the 131 men negative for HSV-2 at baseline, 106 had exit data and 25 (23.6%) incident cases were identified during the one year follow-up period. This resulted in an incidence rate of 23.6 cases/100 pyr. Incidence rates were higher among men with a history of STI (25.0 vs 23.3/100 pyr), positive for HIV (28.6vs 22.8/100 pyr), HPV infection (31.9 vs 16.9/100 pyr), those whose most recent sexual act was with a casual partner/sex worker (44.8 vs 15.6/100 pyr)and those with multiple sexual partners in the last 6 months (31.3 vs. 17.2/100 pyr), 12 months, (33.3 vs. 9.3/100 pyr), and &gt;5 sexual partners lifetime (31.3 vs. 10.3/100 pyr). The incidence rate was much lower among men not engaging in transactional sex (3.8 vs 30.0/100 pyr) and those who</p><table-wrap id="table1"  position="float"><object-id pub-id-type="pii">Table 1</object-id><label>Table 1</label><caption><p>. Baseline viral STI and socio-demographic characteristics of fishermen in the study</p></caption><table><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >All (N = 300)</th><th align="center" valign="middle" >HSV-2 Positive (n = 169)</th><th align="center" valign="middle" >HSV-2 Negative (n = 131)</th></tr></thead><tbody><tr><td align="center" valign="middle" >Age: Mean (SD)</td><td align="center" valign="middle" >27.7 (6.40)</td><td align="center" valign="middle" >29.3 (6.37)</td><td align="center" valign="middle" >25.8 (5.84)</td></tr><tr><td align="center" valign="middle" >18 - 28 years</td><td align="center" valign="middle" >194</td><td align="center" valign="middle" >95 (49.0)</td><td align="center" valign="middle" >99 (75.6)</td></tr><tr><td align="center" valign="middle" >29 - 47 years</td><td align="center" valign="middle" >106</td><td align="center" valign="middle" >74 (68.9)</td><td align="center" valign="middle" >32 (24.4)</td></tr><tr><td align="center" valign="middle" >Marital status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >22 (34.4)</td><td align="center" valign="middle" >42 (32.1)</td></tr><tr><td align="center" valign="middle" >Ever married</td><td align="center" valign="middle" >236</td><td align="center" valign="middle" >147 (62.3)</td><td align="center" valign="middle" >89 (67.9)</td></tr><tr><td align="center" valign="middle" >Circumcised:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >36 (50.0)</td><td align="center" valign="middle" >36 (27.5)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >228</td><td align="center" valign="middle" >133 (58.0)</td><td align="center" valign="middle" >95 (72.5)</td></tr><tr><td align="center" valign="middle" >Sexual partners in last 12 months:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt; 2 partner</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >65 (58.0)</td><td align="center" valign="middle" >47 (35.9)</td></tr><tr><td align="center" valign="middle" >≥ 2 partners</td><td align="center" valign="middle" >188</td><td align="center" valign="middle" >104 (55.3)</td><td align="center" valign="middle" >84 (64.1)</td></tr><tr><td align="center" valign="middle" >Sexual partners lifetime:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤ 5 partners</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >59 (54.6)</td><td align="center" valign="middle" >49 (37.4)</td></tr><tr><td align="center" valign="middle" >&gt; 5 partners</td><td align="center" valign="middle" >192</td><td align="center" valign="middle" >110 (57.3)</td><td align="center" valign="middle" >82 (62.6)</td></tr><tr><td align="center" valign="middle" >Engaged in transactional sex:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >14 (41.1)</td><td align="center" valign="middle" >20 (15.3)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >266</td><td align="center" valign="middle" >155 (58.3)</td><td align="center" valign="middle" >111 (84.7)</td></tr><tr><td align="center" valign="middle" >Baseline HIV status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >230</td><td align="center" valign="middle" >116 (50.4)</td><td align="center" valign="middle" >114 (87.0)</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >53 (75.7)</td><td align="center" valign="middle" >17 (13.0)</td></tr><tr><td align="center" valign="middle" >Baseline HPV status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >151</td><td align="center" valign="middle" >76 (50.1)</td><td align="center" valign="middle" >75 (57.3)</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >93 (62.4)</td><td align="center" valign="middle" >56 (42.7)</td></tr><tr><td align="center" valign="middle" >Kind of partner for recent sexual act:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single men:</td><td align="center" valign="middle" >(N = 69)</td><td align="center" valign="middle" >(n = 24)</td><td align="center" valign="middle" >(N = 45)</td></tr><tr><td align="center" valign="middle" >Girlfriend (regular partner)</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >19 (37.3)</td><td align="center" valign="middle" >32 (71.1)</td></tr><tr><td align="center" valign="middle" >Casual partner/sex worker</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >5 (27.8)</td><td align="center" valign="middle" >13 (28.9)</td></tr><tr><td align="center" valign="middle" >Married men:</td><td align="center" valign="middle" >(N = 231)</td><td align="center" valign="middle" >(n = 145)</td><td align="center" valign="middle" >(n = 86)</td></tr><tr><td align="center" valign="middle" >Wife</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >17 (41.5)</td><td align="center" valign="middle" >24 (27.9)</td></tr><tr><td align="center" valign="middle" >Girlfriend</td><td align="center" valign="middle" >116</td><td align="center" valign="middle" >75 (64.7)</td><td align="center" valign="middle" >41 (47.7)</td></tr><tr><td align="center" valign="middle" >Casual partner/sex worker</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >53 (71.6)</td><td align="center" valign="middle" >21 (24.4)</td></tr><tr><td align="center" valign="middle" >Used condom in recent sexual act:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >18 (42.9)</td><td align="center" valign="middle" >24 (18.3)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >258</td><td align="center" valign="middle" >151 (58.5)</td><td align="center" valign="middle" >107 (81.7)</td></tr><tr><td align="center" valign="middle" >Condom use with new partner:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Most of the time (&gt;75%)</td><td align="center" valign="middle" >107</td><td align="center" valign="middle" >65 (60.7)</td><td align="center" valign="middle" >42 (32.1)</td></tr><tr><td align="center" valign="middle" >Some of the time (25% - 75%)</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >49 (75.4)</td><td align="center" valign="middle" >16 (12.2)</td></tr><tr><td align="center" valign="middle" >Rarely (&lt;25%)</td><td align="center" valign="middle" >128</td><td align="center" valign="middle" >55 (43.0)</td><td align="center" valign="middle" >73 (55.7)</td></tr><tr><td align="center" valign="middle" >Ever had STI:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >223</td><td align="center" valign="middle" >114 (51.1)</td><td align="center" valign="middle" >109 (83.2)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >55 (71.4)</td><td align="center" valign="middle" >22 (16.8)</td></tr></tbody></table></table-wrap><table-wrap id="table2"  position="float"><object-id pub-id-type="pii">Table 2</object-id><label>Table 2</label><caption><p>. Factors associated with baseline HSV-2 infection among fishermen</p></caption><table><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >OR (95% CI)</th><th align="center" valign="middle" >P-value</th><th align="center" valign="middle" >aOR (95% CI)</th><th align="center" valign="middle" >P-value</th></tr></thead><tbody><tr><td align="center" valign="middle" >Age:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 28 years</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >29 - 47 years</td><td align="center" valign="middle" >2.41 (1.42 - 4.11)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >1.96 (1.16 - 2.85)</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >Marital status :</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ever married</td><td align="center" valign="middle" >2.13 (1.02 - 4.93)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >3.80 (1.42 - 11.90)</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Circumcised:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >1.40 (0.82 - 2.38)</td><td align="center" valign="middle" >0.215</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sexual partners in last 12 months:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt; 2 partner</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥ 2 partners</td><td align="center" valign="middle" >0.90 (0.54 - 1.48)</td><td align="center" valign="middle" >0.646</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Lifetime Sexual partners:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤ 5 partners</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt; 5 partners</td><td align="center" valign="middle" >1.11 (0.67 - 1.84)</td><td align="center" valign="middle" >0.655</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Engaged in transactional sex:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >0.50 (0.24 - 1.04)</td><td align="center" valign="middle" >0.062</td><td align="center" valign="middle" >0.56 (0.28 - 1.33)</td><td align="center" valign="middle" >0.189</td></tr><tr><td align="center" valign="middle" >Baseline HIV status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >3.06 (1.67 - 5.61)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >2.22 (1.17 - 4.22)</td><td align="center" valign="middle" >0.015</td></tr><tr><td align="center" valign="middle" >Baseline HPV status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >1.64 (1.03 - 2.60)</td><td align="center" valign="middle" >0.035</td><td align="center" valign="middle" >1.36 (0.78 - 2.37)</td><td align="center" valign="middle" >0.283</td></tr><tr><td align="center" valign="middle" >Partner in recent sexual act:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single men:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Girlfriend (regular)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Casual partner/sex worker</td><td align="center" valign="middle" >1.54 (0.42 - 5.92)</td><td align="center" valign="middle" >0.468</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Married men:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Wife</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Girlfriend</td><td align="center" valign="middle" >2.58 (1.17 - 5.71)</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Casual partner/sex worker</td><td align="center" valign="middle" >3.56 (1.49 - 8.62)</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Condom use in recent sexual act:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >1.88 (0.97 - 3.64)</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >1.06 (0.48 - 2.34)</td><td align="center" valign="middle" >0.885</td></tr><tr><td align="center" valign="middle" >Condom use with new partner:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Most of the time (&gt;75%)</td><td align="center" valign="middle" >0.45 (0.26 - 0.78)</td><td align="center" valign="middle" >0.005</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Rarely (&lt;25%)</td><td align="center" valign="middle" >5.31 (2.29 - 12.33)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >6.34 (2.24 - 13.04)</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Some of the time (25% - 75%)</td><td align="center" valign="middle" >2.03 (0.76 - 5.38)</td><td align="center" valign="middle" >0.155</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ever had STI:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >2.41 (1.38 - 4.22)</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >2.12 (1.19 - 3.91)</td><td align="center" valign="middle" >0.014</td></tr></tbody></table></table-wrap><p>reported condom use on the last sexual act (7.1 vs 33.3/100 pyr) or with new sexual partner (14.5 vs 36.4/100 pyr) as shown in <xref ref-type="table" rid="table3">Table 3</xref>. Bivariate analysis revealed that the number of sexual partners in the last 12 months (IRR, 3.58; 95% CI, 1.32 - 9.71), number of lifetime sexual partners (IRR, 3.06; 95% CI, 1.13 - 8.26) and most recent sexual act with casual partner/sex worker (IRR, 4.40; 95% CI, 1.53 - 12.82) were associated with HSV-2 incidence. Condom use with new sexual partner (IRR, 0.30; 95% CI, 0.10 - 0.83) and lack of transactional sex (IRR, 0.09; 95% CI, 0.01 - 0.71) were protective against incident HSV-2 infection. In multivariate analysis, lack of condom use with new sexual partner (aIRR, 2.53; 95% CI, 1.12 - 7.38), no transactional sex (aIRR, 0.15; 95% CI, 0.08 - 0.95), multiple sexual partners in the last 12 months (aIRR, 4.77; 95% CI, 1.12 - 11.38) and most recent sexual act with casual partner/sex worker (aIRR, 3.03; 95% CI, 1.17 - 8.58) remained significantly associated with incident HSV-2 infection (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Of the 25 cases with incident HSV-2 infection, 15 (60.0%) were infected with persistent HR HPV genotypes compared to 29.6% (24/81) among men who remained HSV-2 negative at study exit. Therefore men with persistent HR HPV infection were 3.6 times more likely to acquire new HSV-2 infection compared to those without (aIRR, 3.35; 95% CI, 1.21 - 11.37). However, baseline HIV infection and exclusive infection with persistent LR HPV genotypes were not associated with HSV-2 incidence (<xref ref-type="table" rid="table3">Table 3</xref>). Among 92 men eligible for incidence evaluation for both HIV and HSV-2, 3 of 5 men with new HIV infection had incident HSV-2 infection compared to 18 of 87 men without new HIV infection. Therefore, men with new HSV-2 infection were 5 times more likely to acquire new HIV infection (IRR, 5.07; 95% CI, 0.91 - 28.37) compared to those without. However, the association between incident HSV-2 infection and HIV acquisition was on the borderline (P = 0.076).</p></sec><sec id="s4"><title>4. Discussion</title><p>Fishermen in this study had a high burden of HSV-2 infection. The estimated baseline HSV-2 prevalence of 56% is over two times higher than the estimated HSV-2 prevalence of 26.3% for men drawn from the general national adult population in Kenya [<xref ref-type="bibr" rid="scirp.46632-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref26">26</xref>] , 26.5% among young men in Kisumu Kenya [<xref ref-type="bibr" rid="scirp.46632-ref16">16</xref>] , 22% among high risk men for HIV in Mombasa, Kenya [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] and 20.3% among MSM in the US [<xref ref-type="bibr" rid="scirp.46632-ref13">13</xref>] . Similar high prevalence (43% - 80%) was previously observed among fishermen along Lake Victoria in Kenya [<xref ref-type="bibr" rid="scirp.46632-ref23">23</xref>] , among patients attending STD clinic in India [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] , among women at high risk for HIV infection in Mozambique [<xref ref-type="bibr" rid="scirp.46632-ref27">27</xref>] and among female sex workers in Mombasa, Kenya [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref24">24</xref>] . Risk factors for prevalent HSV-2 infection (<xref ref-type="table" rid="table2">Table 2</xref>) found in this study (older age, marital status, inconsistent condom use, history of STI, and HIV infection) were consistent with results from other studies [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref24">24</xref>] .</p><p>The HSV-2 incidence rate of 23.6/100 pyr observed in this study, to our knowledge is the highest for HSV-2 among men observed anywhere in the world. Similar HSV-2 incident rates have only been documented among women with high risk sexual behavior. These studies found HSV-2 incidence rate of 23/100 pyr among female sex workers in Mombasa, Kenya [<xref ref-type="bibr" rid="scirp.46632-ref24">24</xref>] , 21.9/100 pyr among female sex workers in China [<xref ref-type="bibr" rid="scirp.46632-ref28">28</xref>] 22.1/100pyr among women at high risk for HIV infection in Mombasa, Kenya [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] and 20.5/100 pyr among women with high risk sexual behavior in Beira, Mozambique [<xref ref-type="bibr" rid="scirp.46632-ref27">27</xref>] . HSV-2 incidence of 11.4/100 pyr was shown among patients attending STD clinic in India [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] and 9.0/100 pyr found among men at high risk for HIV infection in Mombasa, Kenya [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] .</p><p>The rate of new HSV-2 infection in this study was almost 3-5 times that observed (4.9 - 7.4 /100 pyr) in studies evaluating HSV-2 incidence among young men drawn from the general population (in Kenya and Uganda) [<xref ref-type="bibr" rid="scirp.46632-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref29">29</xref>] , and adolescents in the US [<xref ref-type="bibr" rid="scirp.46632-ref30">30</xref>] . Additionally, this study found much higher HSV-2 incidence rate compared to 2.4/100 pyr (with HIV negative partner) - 5.0/100 pyr (with HIV positive partner) for all anal intercourse observed among MSM in the US [<xref ref-type="bibr" rid="scirp.46632-ref13">13</xref>] and 4.0/100 pyr among injection drug users (IDU) in Chiang Mai, Thailand [<xref ref-type="bibr" rid="scirp.46632-ref31">31</xref>] .</p><p>In this study, engagement in transactional sex had a borderline association (P = 0.047) with HSV-2 incidence, although the majority of fishermen reported recent transactional sexual activity. Transactional sex as a risk for HSV-2 acquisition was also observed in other studies [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref25">25</xref>] . Moreover, recent sex with casual partners, multiple sexual partners and inconsistent condom use; found to be independently associated with HSV-2 incidence in this study, were also demonstrated elsewhere [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref30">30</xref>] . A greater (≥3) number of sexual partners in the 12 months prior to study participation was a stronger risk factor for HSV-2 acquisition compared to higher (≥6) number of sexual partners lifetime (<xref ref-type="table" rid="table3">Table 3</xref>). Similarly, Brown et al. (2006) found an increased risk of HSV-2 acquisition strongly associated with a higher number of sexual partners (≥6) and multiple (≥5) unprotected sexual acts, six months prior to study participation [<xref ref-type="bibr" rid="scirp.46632-ref13">13</xref>] . This emphasized that it is not just a temporary sequence of events cumulated in a lifetime but rather the intensity of high-risk sexual events occurring in the period immediately preceding HSV-2 seroconversion.</p><table-wrap id="table3"  position="float"><object-id pub-id-type="pii">Table 3</object-id><label>Table 3</label><caption><p>. Factors associated with incident HSV-2 infection among fishermen</p></caption><table><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >Incidence (%)</th><th align="center" valign="middle" >IRR (95% CI)</th><th align="center" valign="middle" >P-value</th><th align="center" valign="middle" >aIRR (95% CI)</th><th align="center" valign="middle" >P-value</th></tr></thead><tbody><tr><td align="center" valign="middle" >Age:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >26 - 47 years</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >11 (22.0)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 25 years</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >14 (25.0)</td><td align="center" valign="middle" >1.14 (0.57 - 2.27)</td><td align="center" valign="middle" >0.716</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Marital status:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ever married</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >18 (23.4)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >single</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >7 (27.4)</td><td align="center" valign="middle" >1.03 (0.48 - 2.21)</td><td align="center" valign="middle" >0.934</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Circumcised:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >19 (24.7)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >6 (20.7)</td><td align="center" valign="middle" >0.84 (0.37 - 1.89)</td><td align="center" valign="middle" >0.667</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sexual partners in 12 months:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt; 2 partner</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >4 (9.3)</td><td align="center" valign="middle" >0.28 (0.10 - 0.76)</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥ 2partners</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >21 (33.3)</td><td align="center" valign="middle" >3.58 (1.32 - 9.71)</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >4.77 (1.12 - 11.28)</td><td align="center" valign="middle" >0.009</td></tr><tr><td align="center" valign="middle" >Sexual partners in lifetime:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤ 5 partners</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >4 (10.3)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt; 5 partners</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >21 (31.3)</td><td align="center" valign="middle" >3.06 (1.13 - 8.26)</td><td align="center" valign="middle" >0.014</td><td align="center" valign="middle" >3.76 (0.86 - 9.15)</td><td align="center" valign="middle" >0.089</td></tr><tr><td align="center" valign="middle" >Transactional sex:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >24 (30.0)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >1 (3.8)</td><td align="center" valign="middle" >0.09 (0.00 - 0.71)</td><td align="center" valign="middle" >0.006</td><td align="center" valign="middle" >0.15 (0.08 - 0.95)</td><td align="center" valign="middle" >0.047</td></tr><tr><td align="center" valign="middle" >Most recent sexual partner:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Wife/regular girlfriend</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >12 (15.6)</td><td align="center" valign="middle" >0.05 (0.00 - 0.39)</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Casual partner/Sex worker</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >13 (44.8)</td><td align="center" valign="middle" >4.40 (1.53 - 12.82)</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >3.03 (1.17 - 8.58)</td><td align="center" valign="middle" >0.012</td></tr><tr><td align="center" valign="middle" >Condom use with new partner:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥ 50% of the time</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >9 (14.5)</td><td align="center" valign="middle" >0.30 (0.10 - 0.83)</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt; 50% of the time</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >16 (36.4)</td><td align="center" valign="middle" >3.37 (1.21 - 9.56)</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" >2.53 (1.12 - 7.38)</td><td align="center" valign="middle" >0.021</td></tr><tr><td align="center" valign="middle" >Ever use of Condom:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ever used condom</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >17 (20.2)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Never used condom</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >8 (36.4)</td><td align="center" valign="middle" >0.44 (0.14 - 1.38)</td><td align="center" valign="middle" >0.113</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >History of STI:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >21 (23.3)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >4 (25.0)</td><td align="center" valign="middle" >1.10 (0.26 - 4.23)</td><td align="center" valign="middle" >0.885</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Baseline HIV:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >21 (22.8)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4 (28.6)</td><td align="center" valign="middle" >1.35 (0.32 - 5.40)</td><td align="center" valign="middle" >0.637</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Persistent all HPV:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >8 (15.6)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >17 (28.8)</td><td align="center" valign="middle" >2.4 (0.85 - 6.92)</td><td align="center" valign="middle" >0.065</td><td align="center" valign="middle" >1.12 (0.37 - 3.41)</td><td align="center" valign="middle" >0.844</td></tr><tr><td align="center" valign="middle" >Persistent HR HPV:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >10 (14.9)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >15 (38.5)</td><td align="center" valign="middle" >3.56 (1.28 - 10.06)</td><td align="center" valign="middle" >0.006</td><td align="center" valign="middle" >3.35 (1.21 - 11.37)</td><td align="center" valign="middle" >0.009</td></tr><tr><td align="center" valign="middle" >Persistent LR HPV:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >13 (20.6)</td><td align="center" valign="middle" >Reference</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >12 (27.9)</td><td align="center" valign="middle" >1.49 (0.55 - 4.03)</td><td align="center" valign="middle" >0.387</td><td align="center" valign="middle" >Not included</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>To our knowledge, this is the first study to assess HPV infection as a risk factor for incident HSV-2 infection. Therefore, the observed association between persistent HR HPV and new HSV-2 infection warrant further studies and should be interpreted with caution. However, several studies have found that HPV infection increases the risk for HIV acquisition by 1.8 - 3.5 times [<xref ref-type="bibr" rid="scirp.46632-ref32">32</xref>] -[<xref ref-type="bibr" rid="scirp.46632-ref34">34</xref>] . Lissouba et al. (2013) in their meta-analysis review found that HR HPV infection was associated with almost a 2-fold increased risk for incident HIV infection, while LR HPV infection had only a borderline association [<xref ref-type="bibr" rid="scirp.46632-ref35">35</xref>] . Hypothetically, persistent HR HPV infection is biologically necessary for development of HPV disease that may be associated with breach of epithelial membranes and infiltration with pro-inflammatory cytokines and other immune cells. These potentially provide an enabling environment for HSV-2 or HIV entry and replication. Just like HSV-2, HPV is believed to be more infectious than HIV, with prevalence always exceeding that of HIV and the most infectious of the three viruses [<xref ref-type="bibr" rid="scirp.46632-ref36">36</xref>] . Therefore, if the interaction between HSV-2 and HPV found in this study is confirmed by other studies, HPV vaccination would be a recommended strategy for HSV-2 prevention in addition to safer sexual practices.</p><p>HSV-2 and HIV have a common route for transmission and therefore possibly share common factors onhigh-risk sexual behavior. Numerous prevalence studies have shown a strong association between the two sexually transmitted viral infections [<xref ref-type="bibr" rid="scirp.46632-ref37">37</xref>] . Several incidence studies have found prevalent (baseline) HSV-2 infection an important risk factor for new HIV acquisition, with the strongest association emerging between HIV incident and recent or incident HSV-2 infection [<xref ref-type="bibr" rid="scirp.46632-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.46632-ref38">38</xref>] . In these studies, the majority of incident HSV-2 infection events occurred concurrently with or close to the HIV seroconversion events. Therefore, the high HSV-2 incidence rate observed in our current study is likely a strong biological indicator for a rapidly growing HIV epidemic in this population.</p><p>This study had some limitations. Evaluation of the independent role of incident HSV-2 infection on HIV acquisition was limited by the study power, resulting from the small numbers of HIV serocoversion events observed in this study. Additionally, the incidence of these two infections was determined at the end of the study and therefore we could not establish whether HSV-2 incident infection preceded HIV acquisition.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Fishermen are highly burdened and at increased risk for HSV-2 infection characterized by the highest incidence rate ever reported among men, but only comparable to rates documented among female sex workers. Persistent HR HPV infection was independently associated with increased risk for HSV-2 acquisition in addition to factors related to high risk sexual behavior. Without an efficacious HSV-2 vaccine in sight, well-tailored intervention programs promoting safer sex for prevention of HSV-2, HPV and subsequently HIV infections are urgently needed.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We gratefully acknowledge the study participants and the Beach Management Units on the study beaches for their commitment and cooperation during this study. We feel indebted to all the research assistants who worked tirelessly in the field successfully implementing this study. We sincerely appreciate the Director KEMRI and the Director Centre for Microbiology Research (CMR) KEMRI for their unwavering institutional support. This study was fully funded by the Consortium for National Health Research (CNHR) Kenya, Research Leadership Grant (RLG) 026/2009.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.46632-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DICKERSON</surname><given-names> M.C.</given-names></name>,<name name-style="western"><surname> JOHNSTON</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> DELEA</surname><given-names> T.E.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>THE CAUSAL ROLE FOR GENITAL ULCER DISEASE AS A RISK FACTOR FOR TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS. AN APPLICATION OF THE BRADFORD HILL CRITERIA</article-title><source> SEXUALLY TRANSMITTED DISEASES</source><volume> 23</volume>,<fpage> 429</fpage>-<lpage>440</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/00007435-199609000-00015</pub-id></mixed-citation></ref><ref id="scirp.46632-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SCHACKER</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> RYNCARZ</surname><given-names> A.J.</given-names></name>,<name name-style="western"><surname> GODDARD</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> DIEM</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> SHAUGHNESSY</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> COREY</surname><given-names> L. </given-names></name>,<etal>et al</etal>. (<year>1998</year>)<article-title>FREQUENT RECOVERY OF HIV-1 FROM GENITAL HERPES SIMPLEX VIRUS LESIONS IN HIV-1-INFECTED MEN</article-title><source> JAMA</source><volume> 280</volume>,<fpage> 61</fpage>-<lpage>66</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1001/JAMA.280.1.61</pub-id></mixed-citation></ref><ref id="scirp.46632-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O’FARRELL</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> MOODLEY</surname><given-names> P. </given-names></name>,<name name-style="western"><surname> STURM</surname><given-names> A.W. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>GENITAL HERPES IN AFRICA: TIME TO RETHINK TREATMENT</article-title><source> LANCET</source><volume> 370</volume>,<fpage> 2164</fpage>-<lpage>2166</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0140-6736(07)61910-2</pub-id></mixed-citation></ref><ref id="scirp.46632-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MERTZ</surname><given-names> K.J.</given-names></name>,<name name-style="western"><surname> TREES</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> LEVINE</surname><given-names> W.C.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1998</year>)<article-title>ETIOLOGY OF GENITAL ULCERS AND PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS COINFECTION IN 10 US CITIES. THE GENITAL ULCER DISEASE SURVEILLANCE GROUP</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 178</volume>,<fpage> 1795</fpage>-<lpage>1798</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/314502</pub-id></mixed-citation></ref><ref id="scirp.46632-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>PAZ-BAILEY</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> RAMASWAMY</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> HAWKES</surname><given-names> S.J. </given-names></name>,<name name-style="western"><surname> GERETTI</surname><given-names> A.M. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>HERPES SIMPLEX VIRUS TYPE 2: EPIDEMIOLOGYAND MANAGEMENT OPTIONS IN DEVELOPING COUNTRIES</article-title><source> SEXUALLY TRANSMITTED INFECTIONS</source><volume> 83</volume>,<fpage> 16</fpage>-<lpage>22</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/314502</pub-id></mixed-citation></ref><ref id="scirp.46632-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LOOKER</surname><given-names> K.J.</given-names></name>,<name name-style="western"><surname> GARNETT</surname><given-names> G.P. </given-names></name>,<name name-style="western"><surname> SCHMID</surname><given-names> G.P. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>AN ESTIMATE OF THE GLOBAL PREVALENCE AND INCIDENCE OF HERPES SIMPLEX VIRUS TYPE 2 INFECTION</article-title><source> BULLETIN OF THE WORLD HEALTH ORGANIZATION</source><volume> 86</volume>,<fpage> 805</fpage>-<lpage>812</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.2471/BLT.07.046128</pub-id></mixed-citation></ref><ref id="scirp.46632-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TASSIOPOULOS</surname><given-names> K.K.</given-names></name>,<name name-style="western"><surname> SEAGE 3RD</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> SAM</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>PREDICTORS OF HERPES SIMPLEX VIRUS TYPE 2 PREVALENCE AND INCIDENCE AMONG BAR AND HOTEL WORKERS IN MOSHI, TANZANIA</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 195</volume>,<fpage> 493</fpage>-<lpage>501</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/510537</pub-id></mixed-citation></ref><ref id="scirp.46632-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DEL MAR PUJADES RODRIGUEZ</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> OBASI</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> MOSHA</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>HERPES SIMPLEX VIRUS TYPE 2 INFECTION INCREASES HIV INCIDENCE: A PROSPECTIVE STUDY IN RURAL TANZANIA</article-title><source> AIDS</source><volume> 16</volume>,<fpage> 451</fpage>-<lpage>462</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/00002030-200202150-00018</pub-id></mixed-citation></ref><ref id="scirp.46632-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DELANY-MORETLWE</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> LINGAPPA</surname><given-names> J.R. </given-names></name>,<name name-style="western"><surname> CELUM</surname><given-names> C. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>NEW INSIGHTS ON INTERACTIONS BETWEEN HIV-1 AND HSV-2</article-title><source> CURRENT INFECTIOUS DISEASE REPORTS</source><volume> 11</volume>,<fpage> 135</fpage>-<lpage>142</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/00002030-200202150-00018</pub-id></mixed-citation></ref><ref id="scirp.46632-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>REYNOLDS</surname><given-names> S.J.</given-names></name>,<name name-style="western"><surname> RISBUD</surname><given-names> A.R.</given-names></name>,<name name-style="western"><surname> SHEPHERD</surname><given-names> M.E.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>RECENT HERPES SIMPLEX VIRUS TYPE 2 INFECTION AND THE RISK OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ACQUISITION IN INDIA</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 187</volume>,<fpage> 1513</fpage>-<lpage>1521</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/368357</pub-id></mixed-citation></ref><ref id="scirp.46632-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>AARON</surname><given-names> A.R.T.</given-names></name>,<name name-style="western"><surname> VICTOR</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> GODFREY</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> AMY</surname><given-names> E.O.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>INCIDENT HIV AND HERPES SIMPLEX VIRUS TYPE 2 INFECTION AMONG MEN IN RAKAI, UGANDA</article-title><source> AIDS</source><volume> 23</volume>,<fpage> 1589</fpage>-<lpage>1594</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/QAD.0B013E32832D4042</pub-id></mixed-citation></ref><ref id="scirp.46632-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SOBNGWI-TAMBEKOU</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> TALJAARD</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> LISSOUBA</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> ZARCA</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>EFFECT OF HSV-2 SEROSTATUS ON ACQUISITION OF HIV BY YOUNG MEN: RESULTS OF A LONGITUDINAL STUDY IN ORANGE FARM, SOUTH AFRICA</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 199</volume>,<fpage> 958</fpage>-<lpage>964</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/597208</pub-id></mixed-citation></ref><ref id="scirp.46632-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BROWN</surname><given-names> E.L.</given-names></name>,<name name-style="western"><surname> WALD</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> HUGHES</surname><given-names> J.P.</given-names></name>,<name name-style="western"><surname> MORROW</surname><given-names> R.A.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>HIGH RISK OF HUMAN IMMUNODEFICIENCY VIRUS IN MEN WHO HAVE SEX WITH MEN WITH HERPES SIMPLEX VIRUS TYPE 2 IN THE EXPLORE STUDY</article-title><source> AMERICAN JOURNAL OF EPIDEMIOLOGY</source><volume> 164</volume>,<fpage> 733</fpage>-<lpage>741</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/AJE/KWJ270</pub-id></mixed-citation></ref><ref id="scirp.46632-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>FREEMAN</surname><given-names> E.E.</given-names></name>,<name name-style="western"><surname> WEISS</surname><given-names> H.A.</given-names></name>,<name name-style="western"><surname> GLYNN</surname><given-names> J.R.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title> HERPES SIMPLEX VIRUS 2 INFECTION INCREASES HIV ACQUISITION IN MEN AND WOMEN: SYSTEMATIC REVIEW AND META-ANALYSIS OF LONGITUDINAL STUDIES</article-title><source> AIDS</source><volume> 20</volume>,<fpage> 73</fpage>-<lpage>83 
</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/01.AIDS.0000198081.09337.A7</pub-id></mixed-citation></ref><ref id="scirp.46632-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>OKUKU</surname><given-names> H.S.</given-names></name>,<name name-style="western"><surname> S</surname><given-names>ERS</given-names></name>,<name name-style="western"><surname> E.J.</surname><given-names> NYIRO</given-names></name>,<name name-style="western"><surname> J.</surname><given-names> NGETSA</given-names></name>,<name name-style="western"><surname> C.</surname><given-names> ET AL. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>FACTORS ASSOCIATED WITH HERPES SIMPLEX VIRUS TYPE 2 INCIDENCE IN A COHORT OF HIV-1-SERONEGATIVE KENYAN MEN AND WOMEN REPORTING HIGH-RISK SEXUAL BEHAVIOR</article-title><source> SEXUALLY TRANSMITTED DISEASES</source><volume> 38</volume>,<fpage> 837</fpage>-<lpage>844</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/AJE/KWJ270</pub-id></mixed-citation></ref><ref id="scirp.46632-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SUPRIYA</surname><given-names> D.M.</given-names></name>,<name name-style="western"><surname> STEPHEN</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> CORETTE</surname><given-names> B.P.</given-names></name>,<name name-style="western"><surname> KAWANGO</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> MACLEAN</surname><given-names> I. </given-names></name>,<name name-style="western"><surname> BAILEY</surname><given-names> R.C. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>CIRCUMCISION STATUS AND INCIDENT HERPES SIMPLEX VIRUS TYPE 2 INFECTION, GENITAL ULCER DISEASE, AND HIV INFECTION</article-title><source> AIDS</source><volume> 26</volume>,<fpage> 1141</fpage>-<lpage>1149</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/QAD.0B013E328352D116</pub-id></mixed-citation></ref><ref id="scirp.46632-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KISSLING</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> ALLISON</surname><given-names> E.H.</given-names></name>,<name name-style="western"><surname> SEELEY</surname><given-names> J.A.</given-names></name>,<name name-style="western"><surname> RUSSELL</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> BACHMANN</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> MUSGRAVE</surname><given-names> S.D.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>FISHERFOLK ARE AMONG GROUPS MOST AT RISK OF HIV: CROSS-COUNTRY ANALYSIS OF PREVALENCE AND NUMBERS INFECTED</article-title><source> AIDS</source><volume> 19</volume>,<fpage> 1939</fpage>-<lpage>1946</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/01.AIDS.0000191925.54679.94</pub-id></mixed-citation></ref><ref id="scirp.46632-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">OPIO, A., MUYONGA, M. AND MULUMBA, N. (2013) HIV INFECTION IN FISHING COMMUNITIES OF LAKE VICTORIA BASIN OF UGANDA—A CROSS-SECTIONAL SERO-BEHAVIORAL SURVEY. PLOS ONE, 8, E70770. 
HTTP://DX.DOI.ORG/10.1371/JOURNAL.PONE.0070770</mixed-citation></ref><ref id="scirp.46632-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">KIWANUKA, N., SSETAALA, A., MPENDO, J., WAMBUZI, M., NANVUBYA, A., SIGIRENDA, S., ET AL. (2013) HIGH HIV-1 PREVALENCE, RISK BEHAVIOURS, AND WILLINGNESS TO PARTICIPATE IN HIV VACCINE TRIALS IN FISHING COMMUNITIES ON LAKE VICTORIA, UGANDA. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 16, ARTICLE NO. 18621. HTTP://DX.DOI.ORG/10.7448/IAS.16.1.18621</mixed-citation></ref><ref id="scirp.46632-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ASIKI</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> MPENDO</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> ABAASA A.</surname><given-names> AGABA1</given-names></name>,<name name-style="western"><surname> C.</surname><given-names> NANVUBYA</given-names></name>,<name name-style="western"><surname> A.</surname><given-names> NIELSEN</given-names></name>,<name name-style="western"><surname> L.</surname><given-names> ET AL. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>HIV AND SYPHILIS PREVALENCE AND ASSOCIATED RISK FACTORS AMONG FISHING COMMUNITIES OF LAKE VICTORIA, UGANDA</article-title><source> SEXUALLY TRANSMITTED INFECTIONS</source><volume> 87</volume>,<fpage> 511</fpage>-<lpage>515</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1136/STI.2010.046805</pub-id></mixed-citation></ref><ref id="scirp.46632-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KWENA</surname><given-names> Z.A.</given-names></name>,<name name-style="western"><surname> BUKUSI</surname><given-names> E.A.</given-names></name>,<name name-style="western"><surname> NG’AYO</surname><given-names> M.O.</given-names></name>,<name name-style="western"><surname> BUFFARDI</surname><given-names> A.L.</given-names></name>,<name name-style="western"><surname> NGUTI</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>PREVALENCE AND RISK FACTORS FOR SEXUALLY TRANSMITTED INFECTIONS IN A HIGH-RISK OCCUPATIONAL GROUP: THE CASE OF FISHERMEN ALONG LAKE VICTORIA IN KISUMU, KENYA</article-title><source> INTERNATIONAL JOURNAL OF STD &amp; AIDS</source><volume> 21</volume>,<fpage> 708</fpage>-<lpage>713</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1258/IJSA.2010.010160</pub-id></mixed-citation></ref><ref id="scirp.46632-ref22"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>NG’AYO</surname><given-names> M.O.</given-names></name>,<name name-style="western"><surname> BUKUSI</surname><given-names> E.A.</given-names></name>,<name name-style="western"><surname> MORROW</surname><given-names> R.A.</given-names></name>,<name name-style="western"><surname> ROWHANI-RAHBAR</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> OBARE</surname><given-names> B.A.</given-names></name>,<name name-style="western"><surname> FRIEDRICH</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>SEXUAL AND DEMOGRAPHIC DETERMINANTS FOR HERPES SIMPLEX VIRUS TYPE 2 AMONG FISHERMEN ALONG LAKE VICTORIA, KENYA</article-title><source> SEXUALLY TRANSMITTED INFECTIONS</source><volume> 84</volume>,<fpage> 140</fpage>-<lpage>142</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1136/STI.2007.028795</pub-id></mixed-citation></ref><ref id="scirp.46632-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SEELEY</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> NAKIYINGI-MIIRO</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> KAMALI</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> MPENDO</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> ASIKI</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> ABAASA</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>HIGH HIV INCIDENCE AND SOCIO-BEHAVIORAL RISK PATTERNS IN FISHING COMMUNITIES ON THE SHORES OF LAKE VICTORIA, UGANDA</article-title><source> SEXUALLY TRANSMITTED DISEASE</source><volume> 39</volume>,<fpage> 433</fpage>-<lpage>439</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/OLQ.0B013E318251555D</pub-id></mixed-citation></ref><ref id="scirp.46632-ref24"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CHOHAN</surname><given-names> V.</given-names></name>,<name name-style="western"><surname> JARED. M.</surname><given-names> BAETEN</given-names></name>,<name name-style="western"><surname> J.M.</surname><given-names> BENKIE</given-names></name>,<name name-style="western"><surname> S.</surname><given-names> GRAHAM</given-names></name>,<name name-style="western"><surname> S.M.</surname><given-names> ET AL. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>A PROSPECTIVE STUDY OF RISK FACTORS FOR HERPES SIMPLEX VIRUS TYPE 2 ACQUISITION AMONG HIGH-RISK HIV-1 SERONEGATIVE KENYAN WOMEN</article-title><source> SEXUALLY TRANSMITTED INFECTIONS</source><volume> 85</volume>,<fpage> 489</fpage>-<lpage>492</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1136/STI.2009.036103</pub-id></mixed-citation></ref><ref id="scirp.46632-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">KENYA AIDS INDICATOR SURVEY (KAIS) (2007) PRELIMINARY REPORT. KENYA MINISTRY OF HEALTH; NAIROBI, KENYA, 2008. NATIONAL AIDS AND STI CONTROL PROGRAMME.</mixed-citation></ref><ref id="scirp.46632-ref26"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MUGO</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> DADABHAI</surname><given-names> S.S.</given-names></name>,<name name-style="western"><surname> BUNNELL</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> WILLIAMSON</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> BENNETT</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> BAYA</surname><given-names> I.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 2 INFECTION, HUMAN IMMUNODEFICIENCY VIRUS/HERPES SIMPLEX VIRUS TYPE 2 COINFECTION, AND ASSOCIATED RISK FACTORS IN A NATIONAL, POPULATION-BASED SURVEY IN KENYA</article-title><source> SEXUALLY TRANSMITTED DISEASES</source><volume> 38</volume>,<fpage> 1059</fpage>-<lpage>1066</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/OLQ.0B013E31822E60B6</pub-id></mixed-citation></ref><ref id="scirp.46632-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">MEQUE, I., DUBÉ, K., FELDBLUM, P.J., CLEMENTS, A.C.A., ZANGO, A., ET AL. (2014) PREVALENCE, INCIDENCE AND DETERMINANTS OF HERPES SIMPLEX VIRUS TYPE 2 INFECTION AMONG HIV-SERONEGATIVE WOMEN AT HIGH-RISK OF HIV INFECTION: A PROSPECTIVE STUDY IN BEIRA, MOZAMBIQUE. PLOS ONE, 9, E89705. HTTP://DX.DOI.ORG/10.1371/JOURNAL.PONE.0089705</mixed-citation></ref><ref id="scirp.46632-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>WANG</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> REILLY</surname><given-names> K.H.</given-names></name>,<name name-style="western"><surname> SMITH</surname><given-names> M.K.</given-names></name>,<name name-style="western"><surname> BROWN</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> JIN</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> XU</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>HERPES SIMPLEX VIRUS TYPE 2 INCIDENCE AND ASSOCIATED RISK FACTORS AMONG FEMALE SEX WORKERS IN A HIGH HIV-PREVALENCE AREA OF CHINA</article-title><source> INTERNATIONAL JOURNAL OF STD &amp; AIDS</source><volume> 24</volume>,<fpage> 441</fpage>-<lpage>446</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1177/0956462412472800</pub-id></mixed-citation></ref><ref id="scirp.46632-ref29"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>AARON</surname><given-names> A.R.T.</given-names></name>,<name name-style="western"><surname> CHARVAT</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> SSEMPIJJA</surname><given-names> V.</given-names></name>,<name name-style="western"><surname> KIGOZI</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> SERWADDA</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>FACTORS ASSOCIATED WITH THE PREVALENCE AND INCIDENCE OF HERPES SIMPLEX VIRUS TYPE 2 INFECTION AMONG MEN IN RAKAI, UGANDA</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 199</volume>,<fpage> 945</fpage>-<lpage>949</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/597074</pub-id></mixed-citation></ref><ref id="scirp.46632-ref30"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SUDENGA</surname><given-names> S.L.</given-names></name>,<name name-style="western"><surname> KEMPF</surname><given-names> M.C.</given-names></name>,<name name-style="western"><surname> MCGWIN</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> WILSON</surname><given-names> C.</given-names></name>,<name name-style="western"><surname> HOOK</surname><given-names> E.W. </given-names></name>,<name name-style="western"><surname> SHRESTHA</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>INCIDENCE, PREVALENCE AND EPIDEMIOLOGY OF HERPES SIMPLEX VIRUS-2 IN HIV-1-POSITIVE AND HIV-1-NEGATIVE ADOLESCENTS</article-title><source> SEXUALLY TRANSMITTED DISEASES</source><volume> 39</volume>,<fpage> 300</fpage>-<lpage>305</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/OLQ.0B013E318244A90F</pub-id></mixed-citation></ref><ref id="scirp.46632-ref31"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SUTCLIFFE</surname><given-names> C.G.</given-names></name>,<name name-style="western"><surname> ARAMRATTANA</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> SHERMAN</surname><given-names> S.G.</given-names></name>,<name name-style="western"><surname> SIRIROJN</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> GERMAN</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> WONGWORAPAT</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>INCIDENCE OF HIV AND SEXUALLY TRANSMITTED INFECTIONS AND RISK FACTORS FOR ACQUISITION AMONG YOUNG METHAMPHETAMINE USERS IN NORTHERN THAILAND</article-title><source> SEXUALLY TRANSMITTED DISEASES</source><volume> 36</volume>,<fpage> 284</fpage>-<lpage>289</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/OLQ.0B013E318191BA17</pub-id></mixed-citation></ref><ref id="scirp.46632-ref32"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CHIN-HONG</surname><given-names> P</given-names></name>,<name name-style="western"><surname>V.</surname><given-names> HUSNIK</given-names></name>,<name name-style="western"><surname> M.</surname><given-names> CRANSTON</given-names></name>,<name name-style="western"><surname> R.D.</surname><given-names> COLFAX</given-names></name>,<name name-style="western"><surname> G.</surname><given-names> BUCHBINDER</given-names></name>,<name name-style="western"><surname> S.</surname><given-names> ET AL. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>ANAL HUMAN PAPILLOMAVIRUS INFECTION IS ASSOCIATED WITH HIV ACQUISITION IN MEN WHO HAVE SEX WITH MEN</article-title><source> AIDS</source><volume> 23</volume>,<fpage> 1135</fpage>-<lpage>1142</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/QAD.0B013E32832B4449</pub-id></mixed-citation></ref><ref id="scirp.46632-ref33"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SMITH</surname><given-names> J.S.</given-names></name>,<name name-style="western"><surname> MOSES</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> HUDGENS</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> PARKER</surname><given-names> C.B.</given-names></name>,<name name-style="western"><surname> AGOT</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> MACLEAN</surname><given-names> I.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>INCREASED RISK OF HIV ACQUISITION AMONG KENYAN MEN WITH HUMAN PAPILLOMAVIRUS INFECTION</article-title><source> THE JOURNAL OF INFECTIOUS DISEASES</source><volume> 201</volume>,<fpage> 1677</fpage>-<lpage>1685</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1086/652408</pub-id></mixed-citation></ref><ref id="scirp.46632-ref34"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>AVERBACH</surname><given-names> S.H.</given-names></name>,<name name-style="western"><surname> GRAVITT</surname><given-names> P.E.</given-names></name>,<name name-style="western"><surname> NOWAK</surname><given-names> R.G.</given-names></name>,<name name-style="western"><surname> CELENTANO</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> DUNBAR</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> MORRISON</surname><given-names> C.</given-names></name>,<name name-style="western"><surname> ET AL. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>THE ASSOCIATION BETWEEN CERVICAL HUMAN PAPILLOMAVIRUS INFECTION AND HIV ACQUISITION AMONG WOMEN IN ZIMBABWE</article-title><source> AIDS</source><volume> 24</volume>,<fpage> 1035</fpage>-<lpage>1042</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/QAD.0B013E3283377973</pub-id></mixed-citation></ref><ref id="scirp.46632-ref35"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LISSOUBA</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> VAN DE PERRE</surname><given-names> P. </given-names></name>,<name name-style="western"><surname> AUVERT</surname><given-names> B. </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>ASSOCIATION OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION WITH HIV ACQUISITION: A SYSTEMATIC REVIEW AND META-ANALYSIS</article-title><source> SEXUALLY TRANSMITTED INFECTIONS</source><volume> 89</volume>,<fpage> 350</fpage>-<lpage>356</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1136/SEXTRANS-2011-050346</pub-id></mixed-citation></ref><ref id="scirp.46632-ref36"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>VELDHUIJZEN</surname><given-names> N.J.</given-names></name>,<name name-style="western"><surname> SNIJDERS</surname><given-names> P.J.</given-names></name>,<name name-style="western"><surname> REISS</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> MEIJER</surname><given-names> C.J.L.M. </given-names></name>,<name name-style="western"><surname> VAN DE WIJGERT</surname><given-names> J.H.H.M. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>FACTORS AFFECTING TRANSMISSION OF MUCOSAL HUMAN PAPILLOMAVIRUS</article-title><source> THE LANCET INFECTIOUS DISEASES</source><volume> 10</volume>,<fpage> 862</fpage>-<lpage>874</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S1473-3099(10)70190-0</pub-id></mixed-citation></ref><ref id="scirp.46632-ref37"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MBOPI-KEOU</surname><given-names> F.X.</given-names></name>,<name name-style="western"><surname> ROBINSON</surname><given-names> N.J.</given-names></name>,<name name-style="western"><surname> MAYAUD</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> BELEC</surname><given-names> L. </given-names></name>,<name name-style="western"><surname> BROWN</surname><given-names> D.W.G. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>HERPES SIMPLEX VIRUS TYPE 2 AND HETEROSEXUAL SPREAD OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN DEVELOPING COUNTRIES: HYPOTHESES AND RESEARCH PRIORITIES</article-title><source> CLINICAL MICROBIOLOGY AND INFECTION</source><volume> 9</volume>,<fpage> 161</fpage>-<lpage>171</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1046/J.1469-0691.2003.00550.X</pub-id></mixed-citation></ref><ref id="scirp.46632-ref38"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>RAMJEE</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> WILLIAMS</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> GOUWS</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> VAN DYCK</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> DEKEN</surname><given-names> B. </given-names></name>,<name name-style="western"><surname> KARIM</surname><given-names> S.A. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>THE IMPACT OF INCIDENT AND PREVALENT HERPES SIMPLEX VIRUS-2 INFECTION ON THE INCIDENCE OF HIV-1 INFECTION AMONG COMMERCIAL SEX WORKERS IN SOUTH AFRICA</article-title><source> JAIDS JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES</source><volume> 39</volume>,<fpage> 333</fpage>-<lpage>339</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/01.QAI.0000144445.44518.EA</pub-id></mixed-citation></ref></ref-list></back></article>